ConcertoHealth®, the nation’s leading provider of healthcare services for complex, frail, elderly, and Medicare-Medicaid dual-eligible patients, today announced the completion of a $30 million round of financing from existing investors.
After more than three years successfully operating its care model in Renton, WA., to serve dual-eligible Medicare/Medicaid complex medical needs patients in King County, ConcertoHealth (formerly Fidelis SeniorCare) today announced it will be opening two additional Concerto Care Centers in Washington and expanding its partnership with Molina Healthcare in the state.
ConcertoHealth recently announced the appointment of noted health policy expert Mark D. Smith, M.D., M.B.A, to its board of directors.
ConcertoHealth, Inc. (formerly Fidelis SeniorCare) today announced it has divested its insurance assets to focus solely on expanding its innovative healthcare delivery model for dual-eligible Medicare and Medicaid patients.
In the age of Obamacare, healthcare company Fidelis SecureCare is streamlining operations, creating efficiencies, and ensuring better care of its customers. The company is also growing its business in Detroit by taking a slow-food approach to providing healthcare.
Fidelis SeniorCare (“Fidelis” or the “Company”), a successful pioneer and leader in the delivery of extraordinary clinical health care services for seniors, announced the appointment of former WellCare Health Plans chief Alec Cunningham as their new President and Chief Executive Officer. Sam Willcoxon, Founder and former Chief Executive Officer, will remain with the company and assume the role of Chairman.
Deerfield Management Company has just announced that it has entered into a secured loan facility with Fidelis SeniorCare, Inc. for up to $50.0 million in financing.
Fidelis SeniorCare, Inc., a managed care company that administers Medicare Advantage Special Needs Plans to dual eligibles and individuals living in long-term care facilities, announced the completion of a $20.5 million financing led by Arboretum Ventures, which was joined by other new investors Hopen Life Science Ventures, Renaissance Venture Capital Fund and The Kresge Foundation. Also participating in the financing were existing investors Arcapita, CHL Medical Partners, Highland Capital Partners and Versant Ventures. In conjunction with the financing, Tim Petersen of Arboretum joined Fidelis’ board of directors.